- Home
- SIDU vs FGEN Comparison
SIDU vs FGEN Comparison
Compare SIDU & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- FGEN
- Stock Information
- Founded
- SIDU 2012
- FGEN 1993
- Country
- SIDU United States
- FGEN United States
- Employees
- SIDU N/A
- FGEN N/A
- Industry
- SIDU Telecommunications Equipment
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- FGEN Health Care
- Exchange
- SIDU Nasdaq
- FGEN Nasdaq
- Market Cap
- SIDU 30.0M
- FGEN 33.5M
- IPO Year
- SIDU 2021
- FGEN 2014
- Fundamental
- Price
- SIDU $1.73
- FGEN $5.01
- Analyst Decision
- SIDU
- FGEN Strong Buy
- Analyst Count
- SIDU 0
- FGEN 1
- Target Price
- SIDU N/A
- FGEN $250.00
- AVG Volume (30 Days)
- SIDU 702.0K
- FGEN 56.5K
- Earning Date
- SIDU 08-18-2025
- FGEN 08-05-2025
- Dividend Yield
- SIDU N/A
- FGEN N/A
- EPS Growth
- SIDU N/A
- FGEN N/A
- EPS
- SIDU N/A
- FGEN N/A
- Revenue
- SIDU $3,860,985.00
- FGEN $6,996,000.00
- Revenue This Year
- SIDU $144.49
- FGEN N/A
- Revenue Next Year
- SIDU N/A
- FGEN N/A
- P/E Ratio
- SIDU N/A
- FGEN N/A
- Revenue Growth
- SIDU N/A
- FGEN N/A
- 52 Week Low
- SIDU $1.14
- FGEN $4.50
- 52 Week High
- SIDU $7.65
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- SIDU 58.29
- FGEN 31.98
- Support Level
- SIDU $1.49
- FGEN $5.22
- Resistance Level
- SIDU $1.82
- FGEN $5.85
- Average True Range (ATR)
- SIDU 0.13
- FGEN 0.59
- MACD
- SIDU 0.02
- FGEN -0.17
- Stochastic Oscillator
- SIDU 72.73
- FGEN 4.72
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.